A decades-old drug, long used to treat conditions including a chronic parasitic disease, may soon offer new hope for even more patients with a different life-threatening and ultra-rare disorder, Bachmann-Bupp syndrome (BABS). The work is made possible through a new partnership between Corewell Health, Michigan State University and Every Cure.